跳至主要内容
临床试验/NCT03366597
NCT03366597Unknown不适用

Effect of Sevoflurane on the Content of S100β in Infants With Congenital Heart Disease Undergo Cardiac Surgery.

Jun Ma1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Concentration of S100β protein

研究概览

简要总结

To observe the effect of sevoflurane on the concentration of S100β and regional cerebral oxygen saturation in infants with congenital heart disease undergoing cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of congenital heart disease
  • Undergoing heart surgery with cardiopulmonary bypass

排除标准

  • Pulmonary arterial hypertension
  • Sevoflurane allergy

研究组 & 干预措施

Sevoflurane

Experimental

Sevoflurane will be used as a narcotic drug in one group during cardiac surgery.

干预措施: Sevoflurane (Drug)

结局指标

主要结局

Concentration of S100β protein

时间窗: 5 minutes after tracheal intubation; immediately after cardiopulmonary bypass; immediately after operation; 12 hours, 24 hours postoperative

The concentration of S100β protein was performed using the electrochemiluminescence immunoassay.(Blood samples from patients were drawn from central intravenous.)

次要结局

  • Level of regional cerebral oxygen saturation(rScO2)(5 minutes after tracheal intubation; immediately after cardiopulmonary bypass; immediately after operation; 12 hours, 24 hours postoperative)

研究者

发起方
Jun Ma
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jun Ma

The Chief of Anesthesiology Department

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验